International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3, Supplement , Page S331, 1 November 2009

Rapidarc, Intensity Modulated Photon and Proton Techniques for Recurrent Prostate Cancer after Radiotherapy: A Treatment Planning Comparison Study

  • D.C. Weber

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • H. Wang

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • L. Cozzi

      Affiliations

    • Oncology Institute of Southern Switzerland, Medical Physics Unit, Bellinzona, Switzerland
  • ,
  • G. Dipasquale

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • H.G. Khan

      Affiliations

    • Institute of Radiology Jean Violette, Geneva 14, Switzerland
  • ,
  • O. Ratib

      Affiliations

    • Nuclear Medicine, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • M. Rouzaud

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • H. Vees

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • H. Zaidi

      Affiliations

    • Nuclear Medicine, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland
  • ,
  • R. Miralbell

      Affiliations

    • Radiation Oncology, Geneva University Hospital, Campus Cluses Roseraie, Geneva 14, Switzerland

2333

Article Outline

 

Back to Article Outline

Purpose/Objective(s) 

A study was performed comparing volumetric modulated arcs (RA) and intensity modulation (with photons, IMRT, or protons, IMPT) radiation therapy (RT) for patients with recurrent prostate cancer after RT.

Back to Article Outline

Materials/Methods 

Plans for RA, IMRT and IMPT were optimized for 7 patients. Prescribed dose was 56 Gy in 14 fractions. The recurrent gross tumor volume (GTV) was defined on 18F-fluorocholine PET/CT scans. Plans aimed to cover at least 95% of the planning target volume with a dose > 50.4 Gy. A maximum dose (DMax) of 61.6 Gy was allowed to 5% of the GTV. For the urethra, DMax was constrained to 37 Gy. Rectal DMedian was < 17 Gy. Results were analyzed using Dose-Volume Histogram and conformity index (CI90) parameters.

Back to Article Outline

Results 

Tumor coverage (GTV and PTV) was improved with RA (V95% 92.6 ± 7.9 and 83.7 ± 3.3%), when compared to IMRT (V95% 88.6 ± 10.8 and 77.2 ± 2.2%). The corresponding values for IMPT were intermediate for the GTV (V95% 88.9 ± 10.5%) and better for the PTV (V95% 85.6 ± 5.0%). The percentages of rectal and urethral volumes receiving intermediate doses (35 Gy) were significantly decreased with RA (5.1 ± 3.0 and 38.0 ± 25.3%) and IMPT (3.9 ± 2.7 and 25.1±21.1%), when compared to IMRT (9.8 ± 5.3 and 60.7 ± 41.7%). CI90 was 1.3 ± 0.1 for photons and 1.6 ± 0.2 for protons. Integral Dose was 1.1 ± 0.5 Gy∗cm3∗105 for IMPT and about a factor three higher for all photon's techniques.

Back to Article Outline

Conclusions 

RA and IMPT showed improvements in conformal avoidance relative to fixed beam IMRT for 7 patients with recurrent prostate cancer. IMPT showed further sparing of organs at risk.

 Author Disclosure: D.C. Weber, None; H. Wang, None; L. Cozzi, Varian Medical Systems, F. Consultant/Advisory Board; G. Dipasquale, None; H.G. Khan, None; O. Ratib, None; M. Rouzaud, None; H. Vees, None; H. Zaidi, None; R. Miralbell, None.

PII: S0360-3016(09)01801-X

doi:10.1016/j.ijrobp.2009.07.759

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3, Supplement , Page S331, 1 November 2009